CASTLE BIOSCIENCES, INC. Shareholders' Equity
CASTLE BIOSCIENCES, INC. (CSTL) had Shareholders' Equity of $470.03 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-30
- 2026-06-30: Stockholders' Equity Attributable to Parent $470.03M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $461.42M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $470.87M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $467.05M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $470.03M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $461.42M 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $470.87M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $467.05M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $455.38M 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $440.31M 10-Q · filed 2026-07-30 | |
| 2024-12-31 | $455.83M 10-Q · filed 2026-07-30 | |
| 2024-09-30 | $441.06M 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $423.89M 10-Q · filed 2025-11-03 | |
| 2024-03-31 | $402.46M 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $391.27M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $385.78M 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $378.77M 10-Q · filed 2024-11-04 | |
| 2023-03-31 | $385.15M 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $399.15M 10-K · filed 2026-02-26 | |
| 2022-09-30 | $411.43M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $421.66M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $397.34M 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $411.74M 10-K · filed 2025-02-27 | |
| 2021-09-30 | $411.73M 10-Q · filed 2022-11-02 | $411.71M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $415.94M 10-Q · filed 2022-11-02 | $415.92M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $418.61M 10-Q · filed 2022-11-02 | $418.59M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $415.69M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $166.56M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $157.62M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $87.93M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $85.11M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $82.34M 10-Q · filed 2020-11-09 | $82.34M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$50.20M 10-Q · filed 2020-11-09 | -$50.20M 10-Q · filed 2019-09-03 |
| 2019-03-31 | -$49.43M 10-Q · filed 2020-08-10 | -$49.43M 10-Q · filed 2019-09-03 |
| 2018-12-31 | -$56.57M 10-K · filed 2021-03-11 | -$56.57M 10-Q · filed 2019-09-03 |
| 2018-09-30 | -$60.45M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$57.05M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | -$53.93M 10-Q · filed 2019-09-03 | |
| 2017-12-31 | -$50.31M 10-K · filed 2020-03-10 | -$50.31M 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |